Диссертация (1145009), страница 66
Текст из файла (страница 66)
Helicobacte pylori infection causes persistent platelet activation in vivothrough enhanced lipid peroxidation / G. Davi, M. Neri, A. Falco et all //Arterioscler. Thromb. Vasc. Biol. – 2005. – N 25. – P. 246-51.239. Davies M.J. Stability and instability: two faces of coronary atherosclerosis: ThePaul Dudly White Lecture / M.J. Davies // Circulation. – 1996. – N 94. – P. 201320.377240. Davignon J. Role of endothelial dysfunction in atherosclerosis / J. Davignon, P.Ganz // Circulation. – 2004.
– Vol. 109, N 23 (Suppl 1). – P. III27-32.241. De Boer O.J. Atherosclerosis, inflammation and infection / O.J. De Boer, A.C. Vander Wal, A.E. Becker // J. Pathol. – 2000. – N 190. – P. 237-43.242. De Jong R.M. Endothelial dysfunction and reduced myocardial perfusion reservein heart failure secondary to coronary artery disease / R.M. De Jong, P.K. Blanksma,J.H. Cornel et all // Am. J. Cardiol.
– 2003. – N 91. – P. 497-500.243. De Palma R. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologicmechanism / R. De Palma, F. Del Galdo, G. Abbate et all // Circulation. – 2006. – N113. – P. 640-46.244. De Rosa S. Reactive oxygen species and antioxidants in the pathophysiology ofcardiovascular disease: does the actual knowledge justify а clinical approach? / S.De Rosa, Р.
Cirillo, А. Paglia et all // Curr. Vasc. Pharmacol. – 2010. – N 8. – P.259-75.245. Deanfield J.E. Endothelial function and dysfunction: testing and clinical relevance/ J.E. Deanfield, J.P. Halcox, T.J. Rabelink // Circulation. – 2007. – Vol. 115, N 10.– P. 1285-95.246. Demer L.L. Role of inflammation in atherosclerotic calcification, metaplasia andosteoporosis / L.L. Demer, I.V. Tintut, M. Abedin // 19-th Int. Symp. Atheroscler.Int.Congr. – 2004. – P. 570-73.247. Dinarello С.А. Interleukin 1 beta and interleukin 18 as mediators of inflammationand the aging process / С.А.
Dinarello // Am. J. Clin. Nutr. – 2006. – Vol. 83, N 2. –P. 447S-55S.248. Diomedi M. CagA-positive Helicobacter pylori strains may influence the naturalhistory of atherosclerotic stroke / M. Diomedi, A. Pietroiusti, M. Silvestrini et all //Neurology. – 2004. – N 63. – P. 800-804.378249. Dixon М.F. Classification and grading of gastritis. The Updated Sydney System /М.F. Dixon, R.М.
Genta, J.H. Yardley et all // Am. J. Surg. Pathol. – 1996. – Vol.20, N 10. – P. 1161-81.250. Dunlop L.C. Characterization of GMP-140 (P-selectin) as a circulating plasmaprotein / L.C. Dunlop, M.P. Skinner, L.J. Bendall et all // J. Exp. Med. – 1992. – N175. – P. 1147-50.251. Dzierzanowska-Fangrat K. Enhanced gastric IL-18 mRNA expression in Helicobacter pylori-infected children is associated with macrophage infiltration, IL-8, andIL-1 beta mRNA expression / K. Dzierzanowska-Fangrat, J. Michalkiewicz, J.Cielecka-Kuszyk, M.
Nowak et all // Eur. J. Gastroenterol. Hepatol. – 2008. – N 20.– P. 314-19.252. Eaton K.A. Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCIDmice / K.A. Eaton, S.R. Ringler, S.J. Danon // Infect. Immun. – 1999. – N 67. – P.4594-602.253. Elhage R. Reduced atherosclerosis in IL-18 deficient apolipoprotein E-knockoutmice / R. Elhage, J. Jawien, M.
Rudling et all // Cardiovasc. Res. – 2003. – N 59. –P. 234-40.254. Elkind M.S.V. Interleukine-2 levels are associated with carotid artery intima-mediathickness / M.S.V. Elkind, T. Rundek, R.R. Sciacca et all // Atherosclerosis. – 2005.– Vol. 180, N l. – P. 181-87.255. El-Mashad N. Relation of Cag-A-positive Helicobacter pylori strain and some inflammatory markers in patients with ischemic heart diseases / N. El-Mashad, W.M.El-Emshaty, M.S. Arfat et all // Egypt J. Immunol. – 2009. – Vol.
16, N 1. – P. 3947.256. Enarsson K. Helicobacter pylori induces transendothelial migration of activatedmemory T cells / K. Enarsson, M. Brisslert, S. Backert, M. Quiding-Jarbrink // Infect. Immun. – 2005. – N 73. – P. 761-69.379257. Epstein S.E. Infection and atherosclerosis: emerging mechanistic paradigms / S.E.Epstein, Y.F. Zhou, J. Zhu // Circulation. – 1999. – Vol. 100, N 4. – P. e20-28.258.
Erkkila F.T. Autoantibodies against oxidized low density lipoproteins andcardiolipin in patients with coronary heart disease / F.T. Erkkila, O. Narvanen, S.Lehto et all // Arterioscler. Thromb. Vasc. Biol. – 2000. – Vol. 20, N 1. – P. 204209.259. Erl W. HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells / W. Erl, M. Hristov, M. Neureuter et all // Atherosclerosis.
– 2003. – Vol. 169, N 2. – P. 251-58.260. Ernst P. The disease spectrum of Helicobacter pylori: the immunopathogenesis ofgastroduodenal ulcer and gastric cancer / P. Ernst, B.D. Gold // Annu Rev.Microbiol. – 2000. – N 54. – P. 615-40.261. Erridge C. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations inthe Toll-like receptor 4 gene show no deficit lipopolysaccharides signaling / C.Erridge, J. Stewart, I.R. Poxton // J.
Exp. Med. – 2003. – N 197. – P. 1787-91.262. Espinola-Klein C. Impact of infectious burden on extent and long term prognosisof atherosclerosis / C. Espinola-Klein, H.J. Rupprecht, S. Blankenberg et all // Circulation. – 2002. – N 105. – P. 15-21.263. Esterbauer H. Lipid peroxidation and its role in atherosclerosis / H. Esterbauer, G.Waeg, H. Puhl // Br.
Med. Bull. – 1993. – N 49. – P. 566-76.264. Evans C.E. The role of hydrostatic pressure in foam cell formation upon exposureof macrophages to LDL and oxidized LDL / C.E. Evans, S. Mylchreesta, V. Charlton-Menysa et all // Atherosclerosis. – 2008. – Vol. 197, N 2. – P. 596-601.265. Everhart J.E. Recent developments in the epidemiology of Helicobacter pylori /J.E. Everhart // Gastroenterol. Clin. North. Am. – 2000. – N 29. – P.
559-78.266. Fabricant C.G. Virus-induced atherosclerosis / C.G. Fabricant, J. Fabricant, M.M.Litrenta et all // J. Exp. Med. – 1978. – N 148. – P. 335-40.267. Fan J. Inflammatory reactions in the pathogenesis of atherosclerosis / J. Fan, T.Watanabe // J. Atheroscler. Thromb.
– 2003. – Vol. 10, N 2. – P. 63-71.380268. Fan X.J. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells:A mechanism for T-helper cell type 1-mediated damage / X.J. Fan, S.E. Crowe, S.Behar et all // J. Exp. Med. – 1998. – N 187. – P. 1-11.269. Farb A. Coronary plaque erosion without rupture into a lipid core: a frequent causeof coronary thrombosis in sudden coronary death / A.
Farb, A. Burke, A. Tang et all// Circulation. – 1996. – N 93. – P. 1354-63.270. Farsak B. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA inhuman atherosclerotic plaques by PCR / B. Farsak, A. Yildirir, Y. Akyön et all // J.Clin. Microbiol. – 2000. – Vol. 38, N 12. – P. 4408-11.271. Fedele M. Evaluation of immune-inflammatory response in coronary atherosclerosis / M. Fedele, M.
Vercellino, P. Fabbi et all // Ital. Heart J. – 2006. – Vol. 7(suppl1), N 12 (abst).272. Fernandes J.L. Pentoxifylline reduces pro-inflammatory and increases antiinflammatory activity in patients with coronary artery disease: а randomized placebo-controlled study / J.L.
Fernandes, R.Т. de Oliveira, R.L. Mamoni et all // Atherosclerosis. – 2008. – Vol. 196, N 1. – P. 434-42.273. Fienck К.W.Jr. Helicobacter in the developing world / К.W.Jr. Fienck, J. Clemens// Microb. Infect. – 2003. – N 5. – P. 705-13.274. Figura N. Progress in defining the inflammatori cascade / N. Figura // Еur.
J.Gastrotnterol. Hepatol. – 1995. – N 7. – P. 296-302.275. Figura N. Infection by CagA-positive Helicobacter pylori strains in patients withischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalities / N. Figura, A. Palazzuoli, S. Faglia et all // Dig. Dis. Sci. –2002. – N 47. – P. 831-36.276. Fijnheer R. The origin of P-selectin as a circulating plasma protein / R. Fijnheer,C.J. Frijns, J. Korteweg et all.
// Thromb. Haemost. – 1997. – N 77. – P. 1081-85.381277. Fiorentino D.F. Two types of mouse T helper cell. IV. Th2 clones secrete a factorthat inhibits cytokine production by Th1 clones / D.F. Fiorentino, M.W. Bond, T.R.Mosmann // J. Exp.
Med. – 1989. – N 170. – P. 2081-95.278. Fong I.W. Rabbit model for Chlamydia pneumoniae infection / I.W. Fong, В.Chiu, Е. Viira et all // J. Clin. Microb. – 1997. – Vol. 35, N 1. – P. 48-52.279. Franceschi F. Cross-reactivity of anti-CagA antibodies with vascular wall antigens:possible pathogenic link between Helicobacter pylori infection and atherosclerosis /F.
Franceschi, A.R. Sepulveda, A. Gasbarrini et all // Circulation. 2002 – N 106. – P.430-34.280. Franklin В.А. Coronary revascularization and medical management of coronaryartery disease: changing paradigms and perceptions / В.А. Franklin // Eur. J.Cardiovasc. Prev. Rehab. – 2006. – N 5. – P.
669-73.281. Fraser A.G. Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction/ A.G. Fraser, R.K. Scragg, B. Cox, R.T. Jackson // Intern. Med. J. – 2003. – Vol.33, N 7. – P. 267-72.282. Fredrikson G.N. Atheroprotective immunization with MDA-modified apo B-100peptide sequences is associated with activation of the Th2 specific antibody expression / G.N. Fredrikson, L. Andersson, I. Soderberg et all // Autoimmunity.
– 2005. –N 38. – P. 171-179.283. Frostegard J. Autoimmunity, oxidized LDL and cardiovascular disease / J.Frostegard // Autoimmunity Reviews. – 2002. – Vol. 1, N 4. – P. 233-37.284. Frostegard J. Cytokine expression in advanced human atherosclerotic plaques:dominance of proinflammatory (Th1) and macrophage-stimulating cytokines / J.Frostegard, A.K. Ulfragen, P. Nyberg et all // Atherosclerosis.
– 1999. – N 145. – P.33-43.285. Fujimoto K. A new subset of CD103+CD8α+ dendritic cells in the small intestineexpresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity / K.Fujimoto, T. Karuppuchamy, N. Takemura et all // J. Immunol. – 2011. – N 186. –P. 6287-95.382286. Fulop T. Elastin peptides induced oxidation of LDL by phagocytic cells / T. Fulop,A. Larbi, A. Fortun et all // Pathologies Biology. – 2005. – Vol. 53, N 7. – P. 41623.287.
Furnkranz A. Oxidized phospholipids trigger atherogenic inflammation in murinearteries / A. Furnkranz, A. Schober, V.N. Bochkov et all // Arterioscler. Thromb.Vasc. Biol. – 2005. – N 25. – P. 633-41.288. Fuster V. The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts) / V. Fuster, L. Badimon, J.J. Badimon, J.H. Chesebro //N. Engl. J. Med. – 1992. – N 326. – P. 242-50.289. Gabrielli M. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke / M. Gabrielli, A.